Update README.md
Browse files
README.md
CHANGED
|
@@ -1,3 +1,53 @@
|
|
| 1 |
---
|
| 2 |
license: mit
|
| 3 |
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
---
|
| 2 |
license: mit
|
| 3 |
---
|
| 4 |
+
# Data Card: Septic Shock Early Therapy Response Whole-Blood RNA-seq Dataset (GSE110487)
|
| 5 |
+
|
| 6 |
+
## Summary
|
| 7 |
+
|
| 8 |
+
Expression + sample metadata + feature metadata for GSE110487, a
|
| 9 |
+
whole-blood RNA-seq study of septic shock patients profiled for
|
| 10 |
+
transcriptomic differences between early responders and non-responders to
|
| 11 |
+
supportive hemodynamic therapy, assessed by SOFA score improvement within
|
| 12 |
+
the first 48 hours of ICU admission.
|
| 13 |
+
|
| 14 |
+
## Source accession
|
| 15 |
+
|
| 16 |
+
| Accession | N (samples) | N (patients) | Platform | Retrieval source |
|
| 17 |
+
|---|---|---|---|---|
|
| 18 |
+
| GSE110487 | 62 | 31 (17 responders, 14 non-responders) | Illumina Genome Analyzer IIx (GPL10999, 6 samples) + Illumina HiSeq 2500 (GPL16791, 56 samples) | NCBI GEO |
|
| 19 |
+
|
| 20 |
+
Each patient contributed 2 samples: T1 (within 16 hours of ICU admission)
|
| 21 |
+
and T2 (within 48 hours). This SuperSeries splits its 62 samples across
|
| 22 |
+
two sequencing platforms — both were combined to build sample metadata,
|
| 23 |
+
since NCBI's RNA-seq reprocessing counts file pools both platforms into
|
| 24 |
+
one matrix.
|
| 25 |
+
|
| 26 |
+
## Files
|
| 27 |
+
|
| 28 |
+
- `sample_metadata.parquet` — one row per sample: `sample_id`, `patient_id`, `response_to_treatment` (logical; `TRUE` = Responder), `timepoint` (`T1`/`T2`)
|
| 29 |
+
- `feature_metadata.parquet` — one row per gene (`GeneID`, NCBI Entrez Gene ID): NCBI's GRCh38.p13 gene annotation file (`Human.GRCh38.p13.annot.tsv.gz`), matched to the same reprocessing build as the expression data
|
| 30 |
+
- `expression.parquet` — single file, long format: `GeneID`, `sample_id`, `value`
|
| 31 |
+
|
| 32 |
+
## Sample metadata field notes
|
| 33 |
+
|
| 34 |
+
- **`response_to_treatment`** is a per-patient classification (Responder
|
| 35 |
+
vs. Not Responder, defined by SOFA score improvement within 48 hours),
|
| 36 |
+
constant across a patient's T1/T2 samples — unlike some other datasets
|
| 37 |
+
in this collection, this label does not vary by timepoint.
|
| 38 |
+
- **`timepoint`** is T1 (within 16h of ICU admission) or T2 (within 48h).
|
| 39 |
+
28 T1 samples, 34 T2 samples — not perfectly balanced, worth noting if
|
| 40 |
+
used in a paired analysis.
|
| 41 |
+
- All 31 patients have exactly 2 samples (one T1, one T2); no missing
|
| 42 |
+
timepoints.
|
| 43 |
+
- No age or sex data available in the accession's sample-level metadata.
|
| 44 |
+
|
| 45 |
+
## Expression value processing
|
| 46 |
+
|
| 47 |
+
**Raw, un-normalized gene-level counts**, from NCBI's own RNA-seq
|
| 48 |
+
reprocessing pipeline (GRCh38.p13 realignment).
|
| 49 |
+
No filtering or normalization has been applied.
|
| 50 |
+
|
| 51 |
+
## Provenance / reproducibility
|
| 52 |
+
|
| 53 |
+
See [pull_gse110487.R](pull_gse110487.R).
|